Case Report | Open Access
Streptococcus salivarius Prosthetic Joint Infection following Dental Cleaning despite Antibiotic Prophylaxis
We present the case of a 92-year-old man with septic arthritis of a prosthetic hip joint due to Streptococcus salivarius one week following a high-risk dental procedure despite preprocedure amoxicillin. S. salivarius is a commensal bacterium of the human oral mucosa that is an uncommon cause of bacteremia. S. salivarius has previously been described as a causative agent of infective endocarditis and spontaneous bacterial peritonitis but was only recently recognized as a cause of prosthetic joint infection. This case highlights the potential pathogenicity of a common commensal bacteria and the questionable utility of prophylactic antibiotics before dental procedures to prevent periprosthetic joint infections.
As life expectancy increases and the baby boomers reach retirement, joint replacements have become an increasingly common procedure to improve the quality of life of individuals living with osteoarthritis. An estimated 2.5 million Americans are living with artificial hip joints, and over 200,000 join their ranks annually .
Periprosthetic joint infection (PJI) is a rare but serious complication of joint replacement. Estimated rates of PJI following total hip replacement are 0.5–1.6% . These infections are classified into early (0–3 months postoperatively), delayed (3–12 months postoperatively), or late (greater than 12 months postoperatively). Intraoperative contamination is the most common cause of early and delayed PJI, while hematogenous seeding is most often responsible for late infection. The majority of late-onset PJI are caused by Staphylococcus aureus and Staphylococcus epidermis (57%), though about 2% of late PJI are attributable to viridans group streptococci (VGS), a diverse class of alpha-hemolytic commensal bacteria found in the human GI and GU tracts . VGS are divided into 5 major groups: S. anginosus group, S. mitis group, S. mutans group, S. salivarius group, and S. sanguinis group . Though S. salivarius has been implicated in spontaneous bacterial peritonitis  and infective endocarditis [6, 7], it has only recently been reported as the pathogenic agent in prosthetic joint infection . The case presented below identifies S. salivarius as an uncommon commensal cause of late prosthetic joint infection, discusses management of late prosthetic joint infection due to Streptococcus, and serves to remind clinicians that prophylactic antibiotics before dental procedures is neither recommended nor efficacious in the prevention of periprosthetic joint infection in the vast majority of immunocompetent patients.
2. Case Presentation
A 92-year-old man with osteoarthritis and a remote history of right total hip replacement and bilateral total knee replacements presented with a two-day history of severe right hip pain accompanied by nausea, chills, and fatigue. He was unable to bear weight due to pain, and range of motion in his right hip was severely limited. He denied recent trauma or pain in other joints but had undergone routine dental cleaning one week prior to presentation. He had received 2 gm of amoxicillin immediately prior to his dental procedure. He presented afebrile, mildly hypotensive, and was noted to have exquisite tenderness with passive movement of the right leg and reduced range of motion secondary to pain. He had full range of motion and strength distally. He had a leukocytosis of 15,600 WBC per milliliter. Aspiration of right hip joint revealed cloudy fluid with WBC 68,000 cells per milliliter. The patient was resuscitated with IV fluids and started on vancomycin and piperacillin-tazobactam. On the third hospital day, he underwent prosthetic joint drainage and washout with retention of liners. Joint aspirate culture grew Gram-positive cocci in chains, which we subsequently identified by matrix-assisted desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) as S. salivarius. We narrowed antibiotic therapy to ceftriaxone to complete six total weeks of intravenous therapy, after which he was treated with amoxicillin for additional six weeks. At this point, the patient discontinued his oral antibiotics rather than complete a full three months of oral therapy or remain on long-term suppression.
Five months after completion of the above therapy, the patient presented to the ED with hip and back pain following a mechanical fall at home. He was found to have a fracture of L4 and was admitted. On hospital day 5, he was found to have an occult superior dislocation of the R femoral head on CT and an ESR of 71 and CRP of 12.3. He was taken to the OR for single-stage full revision of his prosthesis the following day. One of the three intraoperative cultures had light growth of coagulase-negative staph and S. salivarius, though no WBCs were seen and gram stain was negative. He was treated with 6 weeks of vancomycin and remains on lifelong antibiotic suppression.
Here, we present a case of a late PJI of the hip caused by S. salivarius, a rarely reported cause of infection originating from the oral mucosa, following a dental cleaning. There are several potential reasons that S. salivarius has only recently been recognized in the literature as a cause of PJI. Compared to other species in the VGS family, which already make up less than 2% of PJI, S. salivarius is the least virulent and is often regarded as a contaminant in culture. In one prospective study, less than a third of laboratory-confirmed S. salivarius bacteremia were considered clinically significant, compared with 97% of bacteremia with the closely related S. bovis . In the largest retrospective study of streptococcal PJIs to date and one of the only other studies to identify S. salivarius as a cause of PJI, only 4 cases of nearly 500 streptococcal periprosthetic joint infections were attributed to S. salivarius .
On a more technical basis, many hospital laboratories historically have not speciated VGS organisms, as speciation through classic biochemical testing is time consuming and of only moderate reliability . In the past 5 years, however, widespread use of MALDI-TOF MS has enhanced the ability of clinical microbiology labs to accurately identify infectious agents , including speciation of VGS [11, 12]. This technology enables rapid, consistent identification of microorganisms through comparison of spectral data of cellular proteins from whole-cell patient samples with FDA-approved database of reference spectral signatures of hundreds of species of bacteria and fungi. As VGS speciation through MALDI-TOF MS becomes a mainstream component of clinical microbiology, S. salivarius will likely be recognized as an infrequent but not unanticipated cause of PJI.
Consistent speciation of VGS will improve the care of patients with PJIs through tailored antibiotic regimens and improved study of strain-specific risk factors and outcomes. This is especially important as PJI caused by VGS may be increasing as a proportion of PJIs overall . Identification of species-specific infection trends will enable more detailed retrospective study to identify if the uptick in VGS PJI is driven by the group as a whole or a subset of the family. In addition, several studies have indicated that VGS species differ in antibiotic susceptibility patterns, with S. salivarius having the lowest rates of antibiotic resistance and S. mitis demonstrating the most beta-lactam resistance [3, 14].
In the case at hand, management of this patient’s PJI with debridement, antibiotics, and implant retention (DAIR) was a reasonable choice, given the patient’s age and medical comorbidities, the stability of his prosthetic joint, and the short duration of infectious symptoms prior to presentation. Per the 2012 IDSA guidelines, patients should be considered for DAIR if the joint is less than 30 days old or if the duration of infectious symptoms is less than 21 days in the absence of a draining sinus tract . Extended treatment with beta-lactam antibiotics, like this patient received, is independently associated with improved outcomes for streptococcal PJI treated by DAIR .
Acknowledging that the patient’s clinical presentation at time of recurrence is attributable to his mechanical fall, his elevated ESR and CRP and isolation of S. salivarius from one operative sample five months after completion of initial therapy suggest a possible indolent recurrence of PJI. A large retrospective cohort study of streptococcal PJI managed by DAIR has a failure of treatment in 42.1% of cases, where failure was defined by relapse or persistence of infection, need for salvage therapy, or death related to infection . Even in cases where IDSA criteria were met for washout, the failure rate was still 37%. This patient had several risk factors for recurrence of his PJI after DAIR management. Initial presentation with late PJI is an independent predictor for failure of DAIR after completion of therapy, as is retention of removable components , which was unavoidable given the age of this patient’s prosthesis.
In the effort to prevent this difficult complication of joint replacement, many patients, including the patient in this case, are directed to take prophylactic antibiotics prior to dental procedures. Indeed, dental procedures are associated with transient bacteremia, including VGS bacteremia , and the majority of late PJI arises from hematologic bacterial seeding of the prosthesis . Preprocedure antibiotics reduce the frequency and duration of bacteremia after dental procedures by up to 50% [16, 18]. However, many studies have failed to demonstrate any increased risk of PJI as a result of dental procedure, with or without antibiotic prophylaxis [19–23]. Furthermore, transient bacteremia also occurs with activities of daily living like brushing teeth, flossing, and even chewing [24–26], although the frequency and degree of bacteremia associated with these activities is far less than with dental cleaning or extractions . In the case we present, it remains possible that the patient became bacteremic from tooth brushing or chewing, though it is more likely a result of his recent dental cleaning. The most recent clinical practice guideline from the AAOS reflect the current data and recommend against routine use of prophylactic antibiotics for dental procedures in patients with joint replacement . Nevertheless, it remains common practice for orthopedists to recommend prophylactic antibiotics indefinitely following joint replacement [28, 29].
If patients and physicians seek to reduce the risk of hematogenous PJI from oral flora, attention could be turned to improving oral hygiene. The frequency and magnitude of bacteremia following dental procedures is increased in patients with periodontal disease as compared to those with healthy gums . While there is no evidence directly linking better oral health with reduced risk of PJI, dental hygiene is a low-cost intervention that improves both oral health and individual quality of life. At this time, the AAOS has a consensus recommendation for the improvement or maintenance of appropriate oral hygiene as a means of potentially reducing bacteremia .
In conclusion, late PJI remains an uncommon but challenging complication of joint replacement. Commensal organisms like S. salivarius rarely cause infections even in immunocompetent individuals. Improved identification of causative organisms with microbiologic lab techniques like MALDI-TOF MS will enable us to improve algorithms of care for different infectious agents. Clinicians continue to prescribe antibiotic prophylaxis prior to dental procedures despite the lack of evidence supporting this practice. Increased awareness of current guidelines and data would save health care dollars and prevent unnecessary antibiotic exposure for millions of patients.
Conflicts of Interest
The authors declare that there are no conflicts of interest regarding the publication of this article.
LO and DT were responsible for manuscript writing and references search. GC and CH were involved in manuscript review and reference search.
- S. Kurtz, F. Mowat, K. Ong, N. Chan, E. Lau, and M. Halpern, “Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002,” Journal of Bone and Joint Surgery-American Volume, vol. 87, no. 7, pp. 1487–1497, 2005.
- H. Young, J. Hirsh, E. M. Hammerberg, and C. S. Price, “Dental disease and periprosthetic joint infection,” Journal of Bone and Joint Surgery-American Volume, vol. 96, no. 2, pp. 162–168, 2014.
- C. D. Doern and C.-A. D. Burnham, “It’s not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations,” Journal of Clinical Microbiology, vol. 48, no. 11, pp. 3829–3835, 2010.
- R. Facklam, “What happened to the streptococci: overview of taxonomic and nomenclature changes,” Clinical Microbiology Reviews, vol. 15, no. 4, pp. 613–630, 2002.
- M. Gautam, K. B. Chopra, D. D. Douglas, R. A. Stewart, and S. Kusne, “Streptococcus salivarius bacteremia and spontaneous bacterial peritonitis in liver transplantation candidates,” Liver Transplantation, vol. 13, no. 11, pp. 1582–1588, 2007.
- J. C. Corredoira, M. P. Alonso, J. F. García et al., “Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 24, no. 4, pp. 250–255, 2005.
- L. Felix and R. Gurunathan, ““I can’t believe it’s not bovis”: a case of streptococcus salivarius related endocarditis,” in Proceedings of the Hospital Medicine, Las Vegas, NV, USA, March 2014.
- J. Lora-Tomayo, É. Senneville, A. Ribera et al., “The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: the results of a large multicenter study,” Clinical Infectious Diseases, vol. 64, no. 12, pp. 1742–1752, 2017.
- T. Menon, “Understanding the viridians group streptococci: are we there yet?” Indian Journal of Medical Microbiology, vol. 34, no. 4, pp. 421–426, 2016.
- A. E. Clark, E. J. Kaleta, A. Arora, and D. M. Wolk, “Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology,” Clinical Microbiology Reviews, vol. 26, no. 3, pp. 547–603, 2013.
- S. Angeletti, G. Dicuonzo, A. Avola et al., “Viridans Group Streptococci clinical isolates: MALDI-TOF mass spectrometry versus gene sequence-based identification,” PLoS One, vol. 10, no. 3, Article ID e0120502, 2015.
- M. Marín, E. Cercenado, C. Sánchez-Carrillo et al., “Accurate differentiation of Streptococcus pneumoniae from other species within the Streptococcus mitis group by peak analysis using MALDI-TOF MS,” Frontiers in Microbiology, vol. 8, p. 698, 2017.
- B. T. Bjerke-Kroll, A. B. Christ, A. S. McLawhorn, P. K. Sculco, K. M. Jules-Elysée, and T. P. Sculco, “Periprosthetic joint infections treated with two-stage revision over 14Years: an evolving microbiology profile,” Journal of Arthroplasty, vol. 29, no. 5, pp. 877–882, 2014.
- A. Mathur and A. F. Chen, “Streptococcus viridans periprosthetic joint infections,” Annals of Joint, vol. 2, p. 36, 2017.
- D. R. Osmon, E. F. Berbari, A. R. Berendt et al., “Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of America,” Clinical Infectious Diseases, vol. 56, no. 1, pp. e1–e25, 2013.
- P. B. Lockhart, M. T. Brennan, H. C. Sasser, P. C. Fox, B. J. Paster, and F. K. Bahrani-Mougeot, “Bacteremia associated with toothbrushing and dental extraction,” Circulation, vol. 117, no. 24, pp. 3118–3125, 2008.
- W. Zimmerli, “Prosthetic-joint-associated infections,” Best Practice & Research Clinical Rheumatology, vol. 20, no. 6, pp. 1045–1063, 2006.
- W. A. Coulter, A. Coffey, I. D. F. Saunders, and A. M. Emmerson, “Bacteremia in children following dental extraction,” Journal of Dental Research, vol. 69, no. 10, pp. 1691–1695, 1990.
- J. J. Jacobson, H. D. Millard, R. Plezia, and J. R. Blankenship, “Dental treatment and late prosthetic joint infections,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 61, no. 4, pp. 413–417, 1986.
- E. F. Berbari, D. R. Osmon, A. Carr et al., “Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study,” Clinical Infectious Diseases, vol. 50, no. 1, pp. 8–16, 2010.
- J. Swan, M. Dowsey, S. Babazadeh, A. Mandaleson, and P. F. M. Choong, “Significance of sentinel infective events in haematogenous prosthetic knee infections,” ANZ Journal of Surgery, vol. 81, no. 1-2, pp. 40–45, 2011.
- D. D. Skaar, H. O’Connor, and B. S. Michalowicz, “Dental procedures and subsequent prosthetic joint infections,” Journal of the American Dental Association, vol. 142, no. 12, pp. 1343–1351, 2011.
- F.-C. Kao, Y.-C. Hsu, W.-H. Chen, J.-N. Lin, Y.-Y. Lo, and Y.-K. Tu, “Prosthetic joint infection following invasive dental procedures and antibiotic prophylaxis in patients with hip or knee arthroplasty,” Infection Control & Hospital Epidemiology, vol. 38, no. 2, pp. 154–161, 2017.
- R. P. Roda, Y. Jimenez, E. Carbonell, C. Gavalda, M. M. Munoz, and G. S. Perex, “Bacteremia originating in the oral cavity. A review,” Med Oral Patol Oral Cir Bucal, vol. 13, no. 6, pp. E355–E362, 2008.
- L. Forner, T. Larsen, M. Kilian, and P. Holmstrup, “Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation,” Journal of Clinical Periodontology, vol. 33, no. 6, pp. 401–407, 2006.
- W. G. Guntheroth, “How important are dental procedures as a cause of infective endocarditis?” American Journal of Cardiology, vol. 54, no. 7, pp. 797–801, 1984.
- W. Watters, M. P. Rethman, and N. B. Hanson, “Prevention of orthopaedic implant infection in patients undergoing dental procedures,” Journal of the American Academy of Orthopaedic Surgeons, vol. 21, pp. 180–189, 2013.
- T. Colterjohn, J. de Beer, D. Petruccelli, N. Zabtia, and M. Winemaker, “Antibiotic prophylaxis for dental procedures at risk of causing bacteremia among post-total joint arthroplasty patients: a survey of Canadian orthopaedic surgeons and dental surgeons,” Journal of Arthroplasty, vol. 29, no. 6, pp. 1091–1097, 2014.
- C. M. McNally, R. Visvanathan, S. Liberali, and R. J. Adams, “Antibiotic prophylaxis for dental treatment after prosthetic joint replacement: exploring the orthopaedic surgeon’s opinion,” Arthroplasty Today, vol. 2, no. 3, pp. 123–126, 2016.
Copyright © 2019 Lyra B. Olson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.